awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36271396-46B9C87E-B214-47D7-9E87-F164D43DFD93
Q36271396-46B9C87E-B214-47D7-9E87-F164D43DFD93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36271396-46B9C87E-B214-47D7-9E87-F164D43DFD93
Clinical implications of molecular heterogeneity in triple negative breast cancer.
P2860
Q36271396-46B9C87E-B214-47D7-9E87-F164D43DFD93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36271396-46B9C87E-B214-47D7-9E87-F164D43DFD93
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d686faba4ceba79c429356e22cc72f14ddc9b343
P2860
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40